로딩 중…
지수 로딩 중…
REYON PHARMACEUTICAL CO., LTD
102460· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩9,890+0.10%
2026-06-19
Price Chart
REYON PHARMACEUTICAL CO., LTD-12.56%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 183.82B KRW |
| Revenue | 145.22B KRW |
| Net Income | -23.79B KRW |
| Total Assets | 454.38B KRW |
| Net Assets | 209.58B KRW |
| Employees | 449 |
| Value | |
| P/B | 0.88x |
| P/S | 1.27x |
| FCF Yield | -8.13% |
| Profitability | |
| ROE | -11.35% |
| ROA | -5.24% |
| Op. Margin | -22.81% |
| Revenue Growth | -1.92% |
| Earnings Growth | -5068.68% |
| Financial Health | |
| Debt Ratio | 216.80% |
| Total Debt | 217.88B KRW |
| FCF | -14.95B KRW |
| Cash | 4.29B KRW |
| Current Ratio | 0.52x |
| Dividend | |
| Div. Yield | 1.50% |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | -12.56% |
| 1M Return | -13.78% |
| From 52W High | -31.46% |
| 1Y MDD | -28.87% |
| Trading | |
| Volume | 81,824 shares |
| Foreign Own. | 1.17% |
| Per Share | |
| EPS | -2,184 KRW |
| BPS | 11,427 KRW |
Company Info
Headquartered in Gangnam-gu, Seoul, E-Yang Pharmaceutical was established in 1964, promoting the domestic production of pharmaceutical raw materials and expanding into new technology business finance in 2017. The company holds various prescription medicines for multiple indications, exclusively supplies original medicines like Optiray, and sells active pharmaceutical ingredients such as Tacrolimus. To become a global bio & chemical pharmaceutical company, it collaborates with bio-ventures on new drug development, with its KGMP-certified Chungju factory driving an R&D business model.